Skip to content
★ Sign in to follow
NewcelX Ltd. logo

NewcelX Ltd. Stock: price and insider trades · United States

US·Mcap US$20.1M

No insider purchase over the last 90 days. The latest, by Revel Michel, was filed 29 Apr 2026.

NewcelX Ltd.: what insiders have been doing

Every trade that managers of NewcelX Ltd. disclose to SEC (Form 4) is tracked on this page. The last twelve months, up to 8 November 2026, brought 2 filings signed by 2 insiders.

Not one open-market sale was filed. On the buying side, 2 insiders reported 2 purchases totalling €320k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. One trade stands out by size: a purchase of €192k from Samuel Olivier, disclosed on 29 April 2026. The buyers include 2 senior executives.

The data flag 2 purchases as part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. The last insider purchase was made public on 29 April 2026, 193 days ago.

Compared with its exchange (5,813 companies, median 19 filings), a count of 2 filings is below the norm. Since 2026, the database holds 2 purchases and no sales by insiders of the company.

In the same market, recent insider purchases at GameStop Corp. and Heico Corp also feature in our signals. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Insider Decl.
2
Thresholds
n/a
Buy Volume
€319,870
2 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Michel Revel1 buy
Olivier Samuel1 buy

Since the insiders bought

  • Filed 29 Apr 2026 · 193 days ago · €128k
    -20.2%
    Entry US$4.41 · Close at T+90 US$3.52
  • Filed 29 Apr 2026 · 193 days ago · €192k
    -20.2%
    Entry US$4.41 · Close at T+90 US$3.52

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2025

FY ended December 2025 · cache

US$3.48
Analyst consensus
1 analysts
2.00/5
US$23.00Target US$23.00(+561%)US$23.00
Income statement
EBITDA-US$2.2M
Net income-US$8.3M0.0% margin
Valuation
PER (forward)-5.8x
P/Book2.3x
Balance sheet & cash
Market capUS$20.1M
Total debtUS$355k
Free Cash Flow-US$2.8M
Debt / Equity5%
Profitability & ownership
ROA-25.9%
% insiders68.1%
% institutions1.3%
Last declaration on 29 April 2026
Declarations2 total
  • ▲
    CSO and DirectorExecutives
    149,999 USD31SEC
    54,545 shares@ US$2.75100.0% of flowCommon Shares, par value CHF 0.05 per shareSEC:0001213900-26-049273:0
    Canonical exit: 26 Jul 2026 (T+90)
  • ▲
    DirectorExecutives
    225,000 USD31SEC
    81,818 shares@ US$2.75100.0% of flowCommon Shares, par value CHF 0.05 per shareSEC:0001213900-26-049277:0
    Canonical exit: 26 Jul 2026 (T+90)

2 of 2 declarations

About NewcelX Ltd.

NewcelX Ltd. is a company listed on the XNAS market, specializing in the development of innovative technologies. It focuses on the research and commercialization of solutions in the advanced materials sector.

Recent ranked signals on the same market

Purchases our model currently ranks for the recommendations list.

All recommendations